Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | September 04, 2024 |
| PDB ID ▼ | UniProt ID | Title | Descriptor |
|---|---|---|---|
| 7MJG | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain | Spike glycoprotein |
| 7MJ5 | A2IAB2 | complex of human thrombin with XC-43 | |
| 7MJ5 | P00734 | complex of human thrombin with XC-43 | |
| 7MIY | Q00975 | Human N-type voltage-gated calcium channel Cav2.2 at 3.1 Angstrom resolution | |
| 7MIY | P54284 | Human N-type voltage-gated calcium channel Cav2.2 at 3.1 Angstrom resolution | |
| 7MIY | P54289 | Human N-type voltage-gated calcium channel Cav2.2 at 3.1 Angstrom resolution | |
| 7MIX | Q00975 | Human N-type voltage-gated calcium channel Cav2.2 in the presence of ziconotide at 3.0 Angstrom resolution | |
| 7MIX | P05484 | Human N-type voltage-gated calcium channel Cav2.2 in the presence of ziconotide at 3.0 Angstrom resolution | |
| 7MIX | P54284 | Human N-type voltage-gated calcium channel Cav2.2 in the presence of ziconotide at 3.0 Angstrom resolution | |
| 7MIX | P54289 | Human N-type voltage-gated calcium channel Cav2.2 in the presence of ziconotide at 3.0 Angstrom resolution | |
| 7MIT | Q63664 | Vascular KATP channel: Kir6.1 SUR2B propeller-like conformation 1 | |
| 7MIT | Q63563 | Vascular KATP channel: Kir6.1 SUR2B propeller-like conformation 1 | |
| 7MGW | P31645 | 5-HT bound serotonin transporter reconstituted in lipid nanodisc in NaCl in occluded conformation | |
| 7MGW | 7MGW | 5-HT bound serotonin transporter reconstituted in lipid nanodisc in NaCl in occluded conformation | |
| 7MGD | P02866 | Concanavalin A bound to a DNA glycoconjugate, T(Man-T)TT | |
| 7MGC | P02866 | Concanavalin A bound to a DNA glycoconjugate, G(Man-T)AC | |
| 7MGB | P02866 | Concanavalin A bound to a DNA glycoconjugate, A(Man-T)AT | |
| 7MGA | P02866 | Concanavalin A bound to a DNA glycoconjugate, Man-AAATTT | |
| 7MG9 | P02866 | Concanavalin A bound to DNA glycoconjugates, Man-TTTT and Man-AAAA | |
| 7MG8 | P02866 | Concanavalin A bound to a DNA glycoconjugate, Man-CGCG | |
| 7MG7 | P02866 | Concanavalin A bound to a DNA glycoconjugate, Man-GTAC | |
| 7MG6 | P02866 | Concanavalin A bound to a DNA glycoconjugate, Man-AGCT | |
| 7MG5 | P02866 | Concanavalin A bound to a DNA glycoconjugate, Man-ATAT | |
| 7MFH | Q9R1E6 | Crystal structure of BIO-32546 bound mouse Autotaxin | |
| 7MFG | Q6WG00 | Cryo-EM structure of the VRC310 clinical trial, vaccine-elicited, human antibody 310-030-1D06 Fab in complex with an H1 NC99 HA trimer | |
| 7MFG | Q289M7 | Cryo-EM structure of the VRC310 clinical trial, vaccine-elicited, human antibody 310-030-1D06 Fab in complex with an H1 NC99 HA trimer | |
| 7MFG | 7MFG | Cryo-EM structure of the VRC310 clinical trial, vaccine-elicited, human antibody 310-030-1D06 Fab in complex with an H1 NC99 HA trimer | |
| 7MF1 | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 47D1 | |
| 7MF1 | 7MF1 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 47D1 | |
| 7MEQ | O15393 | Crystal structure of human TMPRSS2 in complex with Nafamostat | |
| 7MEP | 7MEP | BG505 SOSIP.v5.2(7S) in complex with the monoclonal antibodies Rh.33172 mAb.1 and RM19R | |
| 7MEM | C3W5S1 | CryoEM structure of monoclonal Fab 045-09 2B05 binding the lateral patch of influenza virus H1 HA | |
| 7MEM | 7MEM | CryoEM structure of monoclonal Fab 045-09 2B05 binding the lateral patch of influenza virus H1 HA | |
| 7ME5 | Q7JQT0 | Structure of the extracellular WNT-binding module in Drl-2 | |
| 7ME4 | Q9V6K3 | Structure of the extracellular WNT-binding module in Drosophila Ror2/Nrk | |
| 7MDW | 7MDW | CryoEM structure of SARS-CoV-2 RBD in complex with nanobodies Nb21 and Nb105 | |
| 7MDW | P0DTC2 | CryoEM structure of SARS-CoV-2 RBD in complex with nanobodies Nb21 and Nb105 | |
| 7MDU | Q2N0S6 | BG505 SOSIP MD39 in complex with the monoclonal antibodies Rh.33104 mAb.1 and RM20A3 | |
| 7MDU | 7MDU | BG505 SOSIP MD39 in complex with the monoclonal antibodies Rh.33104 mAb.1 and RM20A3 | |
| 7MDT | Q2N0S6 | BG505 SOSIP.v5.2 in complex with the monoclonal antibody Rh4O9.8 (as Fab fragment) | |
| 7MDT | 7MDT | BG505 SOSIP.v5.2 in complex with the monoclonal antibody Rh4O9.8 (as Fab fragment) | |
| 7MD5 | P06213 | Insulin receptor ectodomain dimer complexed with two IRPA-9 partial agonists | |
| 7MD5 | P01308 | Insulin receptor ectodomain dimer complexed with two IRPA-9 partial agonists | |
| 7MBV | S5UH55 | Cryo-EM structure of zebrafish TRPM5 in the presence of 5 mM calcium and 0.5 mM NDNA | |
| 7MBU | S5UH55 | Cryo-EM structure of zebrafish TRPM5 E337A mutant in the presence of 5 mM calcium (high calcium occupancy in the transmembrane domain) | |
| 7MBT | S5UH55 | Cryo-EM structure of zebrafish TRPM5 E337A mutant in the presence of 5 mM calcium (low calcium occupancy in the transmembrane domain) | |
| 7MBS | S5UH55 | Cryo-EM structure of zebrafish TRPM5 in the presence of 6 uM calcium (open state) | |
| 7MBR | S5UH55 | Cryo-EM structure of zebrafish TRPM5 in the presence of 6 uM calcium (apo state) | |
| 7MBQ | S5UH55 | Cryo-EM structure of zebrafish TRPM5 in the presence of 5 mM calcium | |
| 7MBP | S5UH55 | Cryo-EM structure of zebrafish TRPM5 in the presence of 1 mM EDTA |
